Evidence map›Paper›PMID 40216822›Full record

ArticleScientific reports2025

Leveraging ensemble convolutional neural networks and metaheuristic strategies for advanced kidney disease screening and classification.

Abeer Saber, Esraa Hassan, Samar Elbedwehy, Wael A Awad, Tamer Z Emara

Abstract readEvaluation Study
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Abeer SaberInformation Technology Department, Faculty of Computers and Artificial Intelligence, Damietta University, Damietta, Egypt. abeer_saber@du.edu.eg.
Esraa HassanFaculty of Artificial Intelligence, Kafrelsheikh University, Kafrelsheikh, 33511, Egypt.
Samar ElbedwehyDepartment of Data Science, Faculty of Artificial Intelligence, Kafrelsheikh University, Kafrelsheikh, 33511, Egypt.
Wael A AwadComputer Science Department, Faculty of Computers and Artificial Intelligence, Damietta University, Damietta, Egypt.
Tamer Z EmaraInformation Technology Department, Faculty of Computers and Artificial Intelligence, Damietta University, Damietta, Egypt. temara@du.edu.eg.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To address the public health issue of renal failure and the global shortage of nephrologists, an AI-based system has been developed to automatically identify kidney diseases. Recent advancements in machine learning, deep learning (DL), and artificial intelligence (AI) have unlocked new possibilities in healthcare. By harnessing these technologies, we can analyze data to gain insights into symptoms and patterns, ultimately facilitating remote patient care. To create an AI-based diagnosis system for kidney disease, this paper focused on the three major categories of kidney diseases: stones, cysts, and tumors, which were collected and annotated on 12,446 computed tomography (CT) whole abdomen and urogram images. To effectively aid in the automatic identification and diagnosis of kidney diseases, a novel DL model built on the transfer-learning (TL) technology is implemented in this work. DL models are designed to focus on problems, whereas TL uses the knowledge acquired while resolving one issue to another pertinent issue. The proposed model combines multiple DL models to improve overall performance by leveraging the strengths of different architectures, ensembles can enhance accuracy, robustness, and generalization. It enhances the features extracted from MobileNet-V2, ResNet50, and EfficientNet-B0 networks using metaheuristic algorithms and bidirectional long-short-term memory (Bi-LSTM) from the CT image. MobileNetV2, ResNet50, and EfficientNet-B0 hyperparameters have been optimized using a modified grey wolf optimization (GWO) approach for better performance. The suggested model's performance has been measured using five assessment metrics: accuracy, sensitivity, specificity, precision, and area under the ROC curve (AUC) and achieved 99.85% accuracy, 99.8% sensitivity, 99.3% specificity, 98.1% precision, and 1.0 AUC.

Indexed as

Convolutional Neural NetworksDeep LearningKidney DiseasesHumansTomography, X-Ray ComputedComputed tomographyConvolutional neural networkDeep learningOptimizationTransfer learning

Identifiers

PMID40216822
PMCPMC11992196

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.